Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.
30 Oct 18:43 · CNBC
Eli Lilly Stock Dives Toward Worst Day Since 2000 On Disappointing Earnings, Zepbound Sales
Q3 sales in weight loss drugs Mounjaro and Zepbound were more than 20% lower than consensus analyst forecasts, spooking investors.
30 Oct 00:00 · Forbes
last updated on 30 Oct 20:30